Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Il y a 10 min

Redx cleared to start Wnt cancer trial again after safety scare

Hier à 18:42
Redx was hit hard last year when it was forced to suspend a phase 1/2a trial of its porcupine inhibitor for solid tumors, but it’s now been given the OK to restart testing....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Gilead’s clinical research VP moves to U.S.-China NASH startup Terns Pharma

Il y a 5 jours
Gilead’s vice president of clinical research, Erin Quirk, is joining the NASH and cancer-focused Terns Pharmaceuticals as its new chief medical officer....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Artificial Heart Offers Hope to Heart Failure Patients

Il y a 6 jours
A fully artificial heart, developed by the French biotech Carmat, has shown promising interim results in patients with heart failure. Ten patients in Carmat’s ongoing trial were surgically implanted...
labiotech.eu
SANOFI AVENTIS
est cité dans une actualité de L'Usine Nouvelle
Il y a 4 jours

Sanofi refuse de contribuer à l'indemnisation des victimes de la Dépakine

Il y a 5 jours
Le géant pharmaceutique français Sanofi a annoncé le 16 janvier qu'il refusait de contribuer à l'indemnisation des victimes du valproate de... - L'Usine Santé
www.usinenouvelle.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Apple, J&J to put the Apple Watch’s ECG through large-scale clinical testing

Il y a 5 jours
Apple and Johnson & Johnson are teaming up on a multi-year research study to see if the latest Apple Watch can help catch and diagnose elderly people with atrial fibrillation earlier and faster...
www.fiercebiotech.com
SANOFI AVENTIS
est cité dans une actualité de FierceBiotech
Il y a 4 jours

EuroBiotech—More Articles of Note

Il y a 5 jours
In our EuroBiotech roundup this week, Boehringer Ingelheim has penned two new research pacts, Sanofi has bagged bispecific tech and Nanobiotix is planning a U.S. listing. ...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

Il y a 5 jours
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them at risk of long-term complications. Immunotherapy could one day become...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

EuroBiotech Report—EMA-Brexit, AstraZeneca, Juvenescence round, Verona fail and Orchard

Il y a 5 jours
In this week's EuroBiotech Report, EMA raises staff retention forecast, Berman swaps AstraZeneca for Immunocore and Juvenescence raises $46 million....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Scientists Create Prosthetic Ears Using 3D Bioprinting

Il y a 5 jours
Swiss researchers are developing cellulose-based materials for 3D bioprinting, which could lead to implants such as prosthetic ears. 3D-printed implants have big potential in the field of...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Proteus launches its first digital cancer chemotherapy pill

Il y a 5 jours
Smart-pill maker Proteus Digital Health has launched an oral chemotherapy equipped with its ingestible sensor, which aims to help oncologists track treatment effectiveness and adherence in their...
www.fiercebiotech.com
Charger plus d'actualités